Patents by Inventor Constance Peyrottes

Constance Peyrottes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING ACUTE CONDITIONS USING LIPID BINDING PROTEIN-BASED COMPLEXES
    Publication number: 20250360184
    Abstract: Methods for treating acute conditions (e.g., acute conditions comprising acute inflammation), such as cytokine release syndrome, sepsis and acute kidney injury using lipid binding protein-based complexes.
    Type: Application
    Filed: June 9, 2023
    Publication date: November 27, 2025
    Inventors: Cyrille TUPIN, Constance PEYROTTES, Ronald BARBARAS, Stanislas FAGUER
  • CER-001 THERAPY FOR TREATING KIDNEY DISEASE
    Publication number: 20250312366
    Abstract: CER-001 for treating kidney disease, and methods for treating a subject having kidney disease with CER-001.
    Type: Application
    Filed: June 18, 2025
    Publication date: October 9, 2025
    Applicant: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • METHODS FOR TREATING LEUKOCYTOSIS, ENDOTHELIAL DYSFUNCTION AND CARDITIS USING LIPID BINDING PROTEIN-BASED COMPLEXES
    Publication number: 20250255931
    Abstract: Methods for treating leukocytosis, endothelial dysfunction, and carditis comprising administering to a subject a lipid binding protein-based complex.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 14, 2025
    Applicant: ABIONYX PHARMA SA
    Inventors: Cyrille TUPIN, Constance PEYROTTES, Ronald BARBARAS
  • CER-001 therapy for treating kidney disease
    Patent number: 12364705
    Abstract: Disclosed herein is the use of CER-001, a negatively charged lipoprotein complex which comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1?-rac-glycerol) (DPPG) for treating kidney diseases, and methods for treating a subject having kidney diseases with CER-001. For example, the kidney disease can be associated with a lecithin cholesterol acyl transferase (LCAT) deficiency.
    Type: Grant
    Filed: July 21, 2023
    Date of Patent: July 22, 2025
    Assignee: ABIONYX PHARMA SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • METHODS FOR TREATING ACUTE CONDITIONS USING LIPID BINDING PROTEIN-BASED COMPLEXES
    Publication number: 20240033322
    Abstract: Methods for treating acute conditions (e.g., acute conditions comprising acute inflammation), such as cytokine release syndrome, sepsis and acute kidney injury using lipid binding protein-based complexes.
    Type: Application
    Filed: April 15, 2021
    Publication date: February 1, 2024
    Applicant: Abionyx Pharma SA
    Inventors: Cyrille TUPIN, Constance PEYROTTES, Ronald BARBARAS
  • CER-001 THERAPY FOR TREATING KIDNEY DISEASE
    Publication number: 20240016824
    Abstract: CER-001 for treating kidney disease, and methods for treating a subject having kidney disease with CER-001.
    Type: Application
    Filed: July 21, 2023
    Publication date: January 18, 2024
    Applicant: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • CER-001 therapy for treating kidney disease
    Patent number: 11752163
    Abstract: Disclosed herein is the use of CER-001, a negatively charged lipoprotein complex which comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1?-rac-glycerol) (Dipalmitoylphosphatidyl-glycerol; DPPG) for treating kidney diseases, and methods for treating a subject having kidney diseases with CER-001. For example, the kidney disease can be associated with a lecithin cholesterol acyl transferase (LCAT) deficiency.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: September 12, 2023
    Assignee: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • CER-001 THERAPY FOR TREATING KIDNEY DISEASE
    Publication number: 20210322448
    Abstract: CER-001 for treating kidney disease, and methods for treating a subject having kidney disease with CER-001.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 21, 2021
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes